Treatment of hypoglycemia is still based on administration of carbohydrates (oral or parenteral according to the level of consciousness) or, especially in out-of-hospital environments, of glucagon by intramuscular (IM) or subcutaneous (SC) injection. The gene discussed is GCG; the disease is Hypoglycemia.